What is it about?

Influenza and other viruses readily infect cells in culture and, in replicating, they surround themselves with lipid (fat) membranes. Interfering with the processing of these lipids prevents the replication of these viruses as determined by several criteria. Atorvastatin (Lipitor (r) works well at concentrations similar to those used to lower cholesterol, but blocking individual pathways to synthesis of fats or cholesterol does not.

Featured Image

Why is it important?

Using a widely-used medicine or something similar, it should be possible to reduce the severity of a recently-acquired flu infection. This approach could be potentially valuable against other viruses as well, and its potential as a prophylactic (preventive) treatment remains to be explored.

Read the Original

This page is a summary of: Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus, The FASEB Journal, May 2019, Federation of American Societies For Experimental Biology (FASEB),
DOI: 10.1096/fj.201900428rr.
You can read the full text:

Read

Contributors

The following have contributed to this page